{"possibly_sensitive": false, "attachments": {"media_keys": ["3_1275501382649483264"]}, "entities": {"hashtags": [{"start": 18, "end": 26, "tag": "COVID19"}, {"start": 27, "end": 35, "tag": "vaccine"}], "urls": [{"start": 97, "end": 120, "url": "https://t.co/tNEWBa2Yzj", "expanded_url": "https://bit.ly/3hV1n09", "display_url": "bit.ly/3hV1n09"}, {"start": 121, "end": 144, "url": "https://t.co/iBuUaveUMr", "expanded_url": "https://twitter.com/globaltimesnews/status/1275501384050278400/photo/1", "display_url": "pic.twitter.com/iBuUaveUMr"}]}, "reply_settings": "everyone", "created_at": "2020-06-23T18:50:02.000Z", "text": "Chinese-developed #COVID19 #vaccine candidate is world\u2019s first to enter phase 3 clinical trials. https://t.co/tNEWBa2Yzj https://t.co/iBuUaveUMr", "lang": "en", "public_metrics": {"retweet_count": 134, "reply_count": 198, "like_count": 521, "quote_count": 57}, "source": "Buffer", "author_id": "49616273", "conversation_id": "1275501384050278400", "id": "1275501384050278400", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}]}